Anja Radunovic, Ivan Ilic, Milica Matic, Miljana Ostojic, Dejan Kojic, Ana Golocevac, Nikola Lazarevic, Aleksandar Mandic, Milosav Tomovic, Petar Otasevic
{"title":"老年与年轻急性冠脉综合征患者立即冠脉造影后的临床结果","authors":"Anja Radunovic, Ivan Ilic, Milica Matic, Miljana Ostojic, Dejan Kojic, Ana Golocevac, Nikola Lazarevic, Aleksandar Mandic, Milosav Tomovic, Petar Otasevic","doi":"10.3390/jcdd12090362","DOIUrl":null,"url":null,"abstract":"<p><p>(1) Aims: This study aimed to compare cardiovascular outcomes in patients older than 75 years with those of younger patients who underwent interventional treatment for acute coronary syndrome (ACS) at a tertiary university hospital. (2) Methods and Results: This was a retrospective, observational study conducted between January 2016 and December 2021, including 1846 consecutive patients with ACS (older than 75 years <i>n</i> = 203, 11%; younger than 75 years <i>n</i> = 1643, 89%). After admission, patients underwent coronary angiography and subsequently received percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or medical therapy. The mean age in the older group (O75) was 80 ± 4 years versus 59 ± 9 years in the younger group (Y75) (<i>p</i> < 0.001). Older patients more frequently presented with multivessel coronary disease (O75: 114 [56%] vs. Y75: 727 [44%], <i>p</i> = 0.004), and the left anterior descending artery (LAD) was more often the culprit vessel (O75: 105 [52%] vs. Y75: 684 [41%]). Major adverse cardio-cerebral events (MACCEs) occurred more frequently in patients older than 75 years, mainly due to higher mortality (O75: 14 [6.9%] vs. Y75: 27 [1.6%], <i>p</i> < 0.001) and stroke (O75: 3 [1.5%] vs. Y75: 2 [0.1%], <i>p</i> < 0.001). Multivessel disease was the only factor independently associated with MACCEs (HR 1.417, 95% CI 1.058-1.898, <i>p</i> = 0.02). The incidence of significant bleeding (Bleeding Association Research Consortium (BARC) class ≥ 3) was similar between groups (Y75: 123/1643 [7.5%] vs. O75: 13/203 [6.5%], <i>p</i> = 0.587). (3) Conclusions: Patients older than 75 years have worse short- and long-term prognoses following ACS compared with younger patients. Special attention and a multidisciplinary, personalized approach are required to optimize outcomes in this population.</p>","PeriodicalId":15197,"journal":{"name":"Journal of Cardiovascular Development and Disease","volume":"12 9","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12470818/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical Outcomes After Immediate Coronary Angiography in Elderly Versus Younger Patients Suffering from Acute Coronary Syndrome.\",\"authors\":\"Anja Radunovic, Ivan Ilic, Milica Matic, Miljana Ostojic, Dejan Kojic, Ana Golocevac, Nikola Lazarevic, Aleksandar Mandic, Milosav Tomovic, Petar Otasevic\",\"doi\":\"10.3390/jcdd12090362\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>(1) Aims: This study aimed to compare cardiovascular outcomes in patients older than 75 years with those of younger patients who underwent interventional treatment for acute coronary syndrome (ACS) at a tertiary university hospital. (2) Methods and Results: This was a retrospective, observational study conducted between January 2016 and December 2021, including 1846 consecutive patients with ACS (older than 75 years <i>n</i> = 203, 11%; younger than 75 years <i>n</i> = 1643, 89%). After admission, patients underwent coronary angiography and subsequently received percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or medical therapy. The mean age in the older group (O75) was 80 ± 4 years versus 59 ± 9 years in the younger group (Y75) (<i>p</i> < 0.001). Older patients more frequently presented with multivessel coronary disease (O75: 114 [56%] vs. Y75: 727 [44%], <i>p</i> = 0.004), and the left anterior descending artery (LAD) was more often the culprit vessel (O75: 105 [52%] vs. Y75: 684 [41%]). Major adverse cardio-cerebral events (MACCEs) occurred more frequently in patients older than 75 years, mainly due to higher mortality (O75: 14 [6.9%] vs. Y75: 27 [1.6%], <i>p</i> < 0.001) and stroke (O75: 3 [1.5%] vs. Y75: 2 [0.1%], <i>p</i> < 0.001). Multivessel disease was the only factor independently associated with MACCEs (HR 1.417, 95% CI 1.058-1.898, <i>p</i> = 0.02). The incidence of significant bleeding (Bleeding Association Research Consortium (BARC) class ≥ 3) was similar between groups (Y75: 123/1643 [7.5%] vs. O75: 13/203 [6.5%], <i>p</i> = 0.587). (3) Conclusions: Patients older than 75 years have worse short- and long-term prognoses following ACS compared with younger patients. Special attention and a multidisciplinary, personalized approach are required to optimize outcomes in this population.</p>\",\"PeriodicalId\":15197,\"journal\":{\"name\":\"Journal of Cardiovascular Development and Disease\",\"volume\":\"12 9\",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12470818/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Development and Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jcdd12090362\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Development and Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcdd12090362","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
(1)目的:本研究旨在比较某三级大学附属医院75岁以上急性冠脉综合征(ACS)介入治疗患者与年轻患者的心血管结局。(2)方法和结果:这是一项回顾性观察性研究,于2016年1月至2021年12月进行,包括1846例连续的ACS患者(75岁以上n = 203, 11%; 75岁以下n = 1643, 89%)。入院后,患者接受冠状动脉造影,随后接受经皮冠状动脉介入治疗(PCI)、冠状动脉旁路移植术(CABG)或药物治疗。老年组(O75)的平均年龄为80±4岁,年轻组(Y75)的平均年龄为59±9岁(p < 0.001)。老年患者多表现为多支冠状动脉病变(O75: 114 [56%] vs. Y75: 727 [44%], p = 0.004),左前降支(LAD)多为罪魁祸首血管(O75: 105 [52%] vs. Y75: 684[41%])。主要不良心脑事件(MACCEs)在75岁以上患者中发生的频率更高,主要是由于死亡率更高(O75: 14[6.9%]比Y75: 27 [1.6%], p < 0.001)和卒中(O75: 3[1.5%]比Y75: 2 [0.1%], p < 0.001)。多血管疾病是唯一与MACCEs独立相关的因素(HR 1.417, 95% CI 1.058 ~ 1.898, p = 0.02)。显著出血发生率(出血协会研究协会(BARC)分类≥3)组间相似(Y75: 123/1643 [7.5%] vs. O75: 13/203 [6.5%], p = 0.587)。(3)结论:75岁以上ACS患者的短期和长期预后较年轻患者差。需要特别关注和多学科,个性化的方法来优化这一人群的结果。
Clinical Outcomes After Immediate Coronary Angiography in Elderly Versus Younger Patients Suffering from Acute Coronary Syndrome.
(1) Aims: This study aimed to compare cardiovascular outcomes in patients older than 75 years with those of younger patients who underwent interventional treatment for acute coronary syndrome (ACS) at a tertiary university hospital. (2) Methods and Results: This was a retrospective, observational study conducted between January 2016 and December 2021, including 1846 consecutive patients with ACS (older than 75 years n = 203, 11%; younger than 75 years n = 1643, 89%). After admission, patients underwent coronary angiography and subsequently received percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or medical therapy. The mean age in the older group (O75) was 80 ± 4 years versus 59 ± 9 years in the younger group (Y75) (p < 0.001). Older patients more frequently presented with multivessel coronary disease (O75: 114 [56%] vs. Y75: 727 [44%], p = 0.004), and the left anterior descending artery (LAD) was more often the culprit vessel (O75: 105 [52%] vs. Y75: 684 [41%]). Major adverse cardio-cerebral events (MACCEs) occurred more frequently in patients older than 75 years, mainly due to higher mortality (O75: 14 [6.9%] vs. Y75: 27 [1.6%], p < 0.001) and stroke (O75: 3 [1.5%] vs. Y75: 2 [0.1%], p < 0.001). Multivessel disease was the only factor independently associated with MACCEs (HR 1.417, 95% CI 1.058-1.898, p = 0.02). The incidence of significant bleeding (Bleeding Association Research Consortium (BARC) class ≥ 3) was similar between groups (Y75: 123/1643 [7.5%] vs. O75: 13/203 [6.5%], p = 0.587). (3) Conclusions: Patients older than 75 years have worse short- and long-term prognoses following ACS compared with younger patients. Special attention and a multidisciplinary, personalized approach are required to optimize outcomes in this population.